Cooperative Agreement 2243718
Award Date
10/1/23
Completion Date
9/30/25
Dollars Obligated
$1M
Federal Agency
National Science Foundation
Federal Grant Program
47.084
Assistance Type
Cooperative Agreement
Place of Performance
Baltimore, MD 21231, USA
Similar Awards
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Cooperative Agreement award of $1,000,000 to Empo Health, Inc. supports the productization, clinical validation, and quality & regulatory activities for an in-home diabetic foot imaging bathroom scale system. The project aims to develop a novel remote health monitoring product to help reduce severe diabetic foot ulcers, which affect approximately one-quarter of diabetic patients and can lead to...
This Project Grant award from the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (CFDA 47.084) program provides $550,000 to develop a remote monitoring system to reduce morbidity and mortality associated with infections among patients undergoing peritoneal dialysis (PD). The project aims to create a medical device that can enable real-time, continuous, and quantitative monitoring of numerous biomarkers relevant to PD-associated infections. This technology...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Cooperative Agreement award for $997,142 aims to develop a rapid phenylalanine blood level monitor for patients with phenylketonuria (PKU), a lifelong genetic disorder. The product consists of a test strip and device that can provide frequent, accessible monitoring of phenylalanine levels from a finger prick to improve disease management and patient outcomes. The project focuses on optimizing the...
This $997,693 Cooperative Agreement awarded by the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (CFDA 47.084) program aims to develop an interactive health assessment and monitoring platform to improve patient-provider communication and reduce healthcare costs. The project by Literaseed, Inc. integrates electronic health record (EHR) data with natural language processing (NLP) techniques to extract valuable information from medical records, enabling...
This National Science Foundation (NSF) Cooperative Agreement award, under the Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084), provides $999,988 in funding to Dasion Corporation to develop a healthcare technology platform that utilizes geometric unified learning. The platform aims to enhance the efficiency and accuracy of healthcare diagnostics and monitoring, particularly for diseases that can be diagnosed and monitored using data sources like voice and EEG. The project...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $305,000 to Sensvita Inc. supports the development of a non-invasive radiofrequency sensing technology for home-based monitoring of heart and lung function. The project aims to design improved antennas, enhance signal processing techniques, and validate the system's accuracy against clinical benchmarks. The anticipated outcome is a robust and reliable sensor capable of...
The National Science Foundation awarded Vena Vitals Inc. a $1 million cooperative agreement under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084) to develop a wireless, continuous, non-invasive blood pressure monitoring device. The device aims to address the unmet need for real-time blood pressure monitoring of patients undergoing surgery or in critical care by capturing rapid fluctuations with high temporal resolution. Current technologies are limited in accuracy, cost...
This $983,137 Cooperative Agreement award from the National Science Foundation (NSF) under the NSF Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) supports the development of a biofeedback system for adults with Parkinson's disease who have speech disorders. The project aims to create a product that can detect and report on communicative disorders in adults, allowing them to better communicate and live productive lives, while also reducing the overall burden on the...
This National Science Foundation (NSF) Cooperative Agreement award, under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program, provides $999,553 to Dynocardia, Inc. to develop advanced computer vision and artificial intelligence algorithms for motion artifact correction in their Vitrack wearable blood pressure monitoring device. The project aims to improve the accuracy and reliability of Vitrack's continuous, non-invasive blood pressure measurements in clinical settings, where...
This Project Grant award for $305,000 from the National Science Foundation's (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) program will support the development of a novel, non-invasive urine test for early detection of kidney cancer. The primary objectives are to: Demonstrate the specificity and accuracy of a biomarker for detecting early-stage renal tumors in kidney cancer patients without symptoms. Demonstrate the effectiveness and accuracy of the test for detecting residual...